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Renal cell carcinomas (RCCs) comprise 2–3% of all
adult malignancies and 85% of malignant renal tumors.
The highest incidence is in individuals in the sixth and
seventh decades of life, with a median age at diagnosis
of 66 years [1]. Characteristically, the tumor is slow-
growing and encapsulated in its early stages and thus
asymptomatic [2]. In some cases, metastasis precedes
the clinical manifestations of the primary tumor [3].
In a review of 128 articles, Wahner-Roedler and Sebo
found that metastasis was described in about 50 dif-
ferent sites [4]. Among these, the calvarium was an
extremely unusual site of metastasis, which was only
mentioned in a few case reports [5–7].
CASE PRESENTATION
An 80-year-old man was admitted to the neurosurgery
department for evaluation of a mass on the left parietal
scalp area, which was accidentally noted by the patient
1 week prior to consult. The mass was soft and painless,
measuring approximately 5×4 cm. The patient denied
any head trauma history and no neurologic symptoms
were found. Specifically, there was no hematuria, flank
pain, or weight loss.
Physical examination revealed a skull defect in the
left parietal bone. The overlying mass was non-tender
and pulsatile on palpation. The patient’s visual fields
were full, and results of the neurologic examination
were unremarkable.
Skull radiograph showed a well-defined radiolu-
cent lesion at the left parietal bone, simulating a prom-
inent venous lake. However, computed tomography
(CT) scan revealed a soft tissue lesion in the left parietal
bone with marked bone destruction, intracranial
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The occurrence of metastasis to the head and neck region in renal cell carcinoma is extremely rare.
An 80-year-old man presented with a soft nodule in the left parietal calvarium and was admitted
to our hospital. Biopsy of the nodule showed nests of clear tumor cells, suggesting metastatic
renal cell carcinoma. Computed tomography of the abdomen revealed a well-defined hypervas-
cular tumor, measuring around 7×7×8 cm, exophytic from the lower pole of the right kidney.
Since there were no other systemic metastases, right nephrectomy and complete resection of the
skull lesion were performed. No adjunctive therapy was given postoperatively. After 22 months
of follow-up, the patient was well and without evidence of disease.
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extension with compression of the dura, and invasion
of the soft tissues of the scalp, suggesting a malignant
tumor or a metastatic lesion (Figure 1A). Results of
chest X-ray, complete blood count, serum electrolyte
levels, and urinalysis were within normal limits.
Needle biopsy was performed and permanent
section of the obtained specimen showed large cells
with abundant cytoplasm, marked nuclear atypia,
and prominent nucleoli. Using light microscopy, the
pathologist interpreted the specimen as metastatic RCC
composed of nests of clear tumor cells with delicate
vascular plexus and hemorrhage.
Abdominal CT showed a well-defined 7×7×8 cm
hypervascular tumor exophytic from the lower pole
of the right kidney, suggestive of RCC (Figure 1B).
No para-aortic/pelvic lymphadenopathies or other
bony lytic lesions were identified. Total body bone
scintigraphy revealed increased radionuclide activity
(hot region) at the left fronto-parieto-temporal skull,
consistent with metastatic bone disease.
The diagnosis of metastatic RCC was established
and the patient was transferred to the urology ward
and underwent right radical nephrectomy. Although
much perirenal adipose tissue and neovasculariza-
tion were encountered, the operation was performed
smoothly. Total resection of the metastatic skull lesion
and cranioplasty were also done. The tumor had in-
vaded the skin and was necrotic in its deeper parts.
Complete erosion of the underlying skull bone was
found and parts of the tumor extended into the dura.
Gross pathologic examination showed an elastic,
mottled grayish-yellow mass that measured 7.5×7.3×
7.0 cm in size, the cut surface of which revealed foci
of necrosis and hemorrhage. Microscopic evaluation
of sections stained with hematoxylin-eosin revealed
a well-demarcated tumor composed of polygonal
tumor cells with clear cytoplasm and hyperchromatic
nuclei, findings typical of conventional (clear cell)
RCC (Figure 2A). The histologic grade was Fuhrman
grade 3 and the pathology stage was pT2N0M1. The
tumor was confined to the renal parenchyma with ten-
dency to penetrate the renal capsule. Both the skull
bone and the dura showed infiltrating metastatic RCC
(Figure 2B). The patient was discharged 10 days after
surgery, revealing no evidence of local recurrence or
distant metastasis during the 22-month follow-up.
DISCUSSION
RCC is a tumor with an unpredictable clinical course
and behavior. Metastases have been reported to de-
velop 17 years or more after the primary lesion is
removed [8]. The most frequent metastatic locations are
the lungs, bone, liver, and adrenal glands. RCC is the
third most likely infraclavicular tumor to metastasize
to the head and neck area, preceded only by breast
and lung carcinomas [9]. Around 14–16% of patients
with RCC have metastases in this area, 8% of which
presents as the first clinical manifestation of the disease
Figure 1. (A) Axial computed tomography (CT) scan of the head shows a mass lesion at the left parietal area of the skull with bone
destruction. (B) Axial CT scan of the abdomen reveals a well-enhanced tumor (arrow) with central necrosis in the right kidney.
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[10]. Namely, only 1% of RCC patients have no other
obvious metastasis except the head and neck [11].
RCC frequently invades the local vascular network
by direct extension. It has been postulated that metas-
tatic RCC cells can reach the head and neck area by
normal hematogenous flow through the lungs, leaving
microscopic seeding in the lung parenchyma, which
may not be visible on chest radiograph [12]. However,
the most important route of metastasis seems to be
tumoral embolization via the Batson plexus, namely
the anastomosis between the avalvular vertebral and
epidural venous system [13]. This can explain the
lack of lung metastases in patients with positive head
and neck lesions.
The patient described here presented with scalp
swelling and intact overlying skin. In light of the oper-
ative findings, the skin and dura involvement appeared
to be invasion from a cranial deposit. We suppose that
the route of spread to the scalp in this case was hema-
togenous to the parietal bone and from there, by direct
invasion to the scalp and dura.
The standard of care for localized and metastatic
RCC includes radical nephrectomy. Historically, the
role of surgery in metastatic RCC is for diagnosis and
debulking of disease. At present, metastatic deposits
have been known to disappear following resection of
the primary lesion [14]. Complete spontaneous regres-
sion of pulmonary and bone metastases after removal
of the primary tumor has been described, which oc-
curred due to immunologic reactions [15]. Although
the actual incidence is low, patients with bizarre spread
of RCC to the head and neck region may have rela-
tive resistance to pulmonary metastases [12]. Long-
term survival of this patient here may provide evidence
for this hypothesis.
Patients who have an asymptomatic RCC but have
signs and symptoms referable to a site of metastasis
(as in our patient) have a diagnostically challenging
subset of stage IV disease [4]. Imaging procedures do
not reveal specific features. Radiologic diagnosis is
based on the vascular nature of the tumor, which is
moderate to marked signal enhancement on contrast
CT. If enhancement with contrast, destruction, and
lack of tumor calcification are noted on CT of the
head and neck, metastatic RCC should be part of the
differential diagnoses [16].
Most patients initially present with metastatic RCC
that is suggestive of a widely disseminated disease
and have a median survival of 1 year [17]. Moreover,
synchronous detection of solitary metastasis with pri-
mary tumor is considered an unfavorable feature [18].
Nevertheless, aggressive surgical treatment can still
produce the best palliative results in this particular
subset of patients, and even long-term survival in
some cases [19]. A study of 59 RCC patients in whom
surgical resection of solitary metastases was performed
resulted in 3- and 5-year survival rates of 45% and
34%, respectively [20].
Renal tumors are frequently accompanied by bone
metastases. However, few cases have been described
RCC presenting with skull metastasis
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Figure 2. Histology pictures. (A) The kidney shows a well-demarcated tumor composed of polygonal tumor cells with clear cytoplasm
and hyperchromatic nuclei (insert). (B) There are infiltrative tumor nests in the marrow spaces of the skull. The photograph shows
tumor cells similar to renal cell carcinoma of the kidney (insert). (Hematoxylin and eosin; magnification, 40×; insert photograph 
magnification, 400×.)
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of metastases occurring in the skull. Forbes et al re-
viewed 1,668 patients with RCC and only five patients
presented with skull metastasis [21]. The case reported
here confirms that the paradoxical sites of metastasis
from RCC should be considered by clinicians. RCC
should be part of the differential diagnoses of grow-
ing lesions in the head and neck. Furthermore, local
resection without sacrifice of vital structures is the
treatment of choice depending on the site of presen-
tation. This may provide a chance to cure the head
and neck metastasis and avoid associated morbidity
that may occur if the lesion is left untreated. This
patient had a slow-growing tumor and remained well
despite the stage of the disease and the spread to the
cranium.
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